Figure 3
Figure 3. Decreased accumulation of CCR8 −/− Tregs after transplant day +7. (A-C). B6D2 recipients were lethally irradiated on day –1 and then administered 3 × 106 TCD BM cells from WT eGFP– B6 donors plus 1 × 106 column-purified CD4+CD25+ Tregs from WT eGFP+ B6 or CCR8−/− eGFP+ B6 mice on day 0. Then 4 × 106 CD25-depleted eGFP– Tcons from WT B6 donors were administered on day +2. Recipient animals were anesthetized on transplant days +7 (A), +10 (B), or +14 (C), and lymphoid organs imaged by fluorescence stereomicroscopy. Total eGFP levels were then quantified in these sites using an eGFP ELISA kit. (A) n = 4 recipients per group. (B) n = 5 recipients per group. *P = .008 for total eGFP comparison between WT and CCR8−/− Treg recipients by the Mann-Whitney test. **P = .032. (C) n = 8 WT Treg and 5 CCR8−/− Treg recipients. *P = .019; **P = .011.

Decreased accumulation of CCR8 −/− Tregs after transplant day +7. (A-C). B6D2 recipients were lethally irradiated on day –1 and then administered 3 × 106 TCD BM cells from WT eGFP B6 donors plus 1 × 106 column-purified CD4+CD25+ Tregs from WT eGFP+ B6 or CCR8−/− eGFP+ B6 mice on day 0. Then 4 × 106 CD25-depleted eGFP Tcons from WT B6 donors were administered on day +2. Recipient animals were anesthetized on transplant days +7 (A), +10 (B), or +14 (C), and lymphoid organs imaged by fluorescence stereomicroscopy. Total eGFP levels were then quantified in these sites using an eGFP ELISA kit. (A) n = 4 recipients per group. (B) n = 5 recipients per group. *P = .008 for total eGFP comparison between WT and CCR8−/− Treg recipients by the Mann-Whitney test. **P = .032. (C) n = 8 WT Treg and 5 CCR8−/− Treg recipients. *P = .019; **P = .011.

Close Modal

or Create an Account

Close Modal
Close Modal